MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015
MERS, coronavirus, Antibody, serology, Kinetics, human
We investigated the kinetics of the Middle East respiratory syndrome coronavirus (MERS-CoV) neutralizing and spike protein antibody titers over the course of 1 year in 11 patients who were confirmed by reverse transcription PCR to have been infected during the outbreak in South Korea in 2015. Robust antibody responses were detected in all survivors who had severe disease; responses remained detectable, albeit with some waning, for
Pyoeng Gyun Choe, R.A.P.M. Perera, Wan Beom Park, Kyoung-Ho Song, Ji-Hwan Bang, Eu Suk Kim, Hong Bin Kim, Long Wei Ronald Ko, Sangwon Park, Nam Joong Kim, Eric H. Y. Lau, Leo L.M. Poon, Myoung-don Oh
Centers for Disease Control and Prevention
Infectious and parasitic diseases, Medicine